Gastroenterology and Hepatology - Clinical Practice

Episodes 1-16 of 50

- Anthony J. Lembo, MD
  Peer
17
CME/CE
IBS-D: A Case Study Approach to Improved Screening & Detection
- Bincy P. Abraham, MD, MS
  Peer
- Jason Ken Hou, MD, MS, FACG
  Peer
- Siddharth Singh, MD
  Peer
15
CME/CE
Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease
- Jeffrey B. Danzig, MD
  Peer
18
CME/CE
IBS-D: The Role of Pathophysiology in Assessment & Treatment
- Darren M. Brenner, MD, AGAF
  Peer
15
CME/CE
IBS-D: What to Do when Typical Treatment Methods Fail
- Vincent A. Mukkada, MD
  Peer
18
CME/CE
Management Essentials for Pediatric Eosinophilic Esophagitis Patients
- Adam S. Cheifetz, MD
  Peer
- Alan C. Moss, MD
  Peer
9
CME/CE
New Directions on Therapeutic Drug Monitoring in IBD
- Benjamin A. Weinberg, MD
  Peer
3
Conversations on Colorectal Cancer
Unraveling Disease Progression Predictors of mCRC
- Benjamin A. Weinberg, MD
  Peer
2
Conversations on Colorectal Cancer
Right-Left Divide: Prognostic Importance of Tumor Sidedness
- Benjamin A. Weinberg, MD
  Peer
2
Conversations on Colorectal Cancer
NCCN Guidelines on mCRC in an Era of Tumor Sidedness
- Benjamin A. Weinberg, MD
  Peer
1
Conversations on Colorectal Cancer
Expanding NCCN Guidelines for mCRC Care
- Edmond Bendaly, MD, FACP
  Peer
16
Conversations on Colorectal Cancer
The Standouts: One Colorectal Cancer Patient’s Story
- Richard Kim, MD
  Peer
4
Conversations on Colorectal Cancer
What Is the Role of KRAS Testing in Therapeutic Decision Making for mCRC?
- Richard Kim, MD
  Peer
3
Conversations on Colorectal Cancer
mCRC Case Review: How to Make Informed Decisions for Personalized Treatment
- Shira Johnson, MD
  Peer
- Edmond Bendaly, MD, FACP
  Peer
19
Conversations on Colorectal Cancer
The Role of Targeted Therapy in Metastatic Colorectal Cancer Patient Care
- Richard Kim, MD
  Peer
5
Conversations on Colorectal Cancer
How mCRC Tumor Sidedness Guides Treatment Decisions
- Allan Gibofsky, MD, JD, MACR, FACP, FCLM
  Peer
- Bruce E. Sands, MD, MS
  Peer
14
CME/CE
JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

Prev
1
2
3
4
Next

1/4